Xoma | XOMA - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -3.27B 628M 2025-12
Agenus USD -271.11M 3.03M 2025-12
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Ardelyx USD 166.95M 12.67M 2025-12
aTyr Pharma USD -24.12M 104.35M 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Celldex Therapeutics USD 527.16M 71.2M 2025-12
Curis USD 5.46M 19.45M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Incyte USD 5.17B 516.28M 2025-12
MacroGenics USD 55.59M 11.41M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Novartis USD 46.13B 1.8B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Prothena USD 280.47M 14.51M 2025-12
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Xoma USD 87.94M 15.5M 2025-09